Mammals achieve dosage compensation by transcriptional silencing of one X-chromosome in early female development. X-chromosome inactivation (XCI) is controlled by a master locus known as the """"""""X-inactivation center,"""""""" a cis-acting center which is both necessary and sufficient to direct X-chromosome counting, choice, and initiation of silencing. Our long term goal is to understand the molecular underpinnings of each step. It is currently known that Xist RNA, a non-coding product of the X-inactivation center, """"""""paints"""""""" the inactive X and is required to initiate global silencing of that X. Work from the last funding period led to the discovery of two novel non-coding RNA loci at the X-inactivation center. Tsix, a gene antisense to Xist, inhibits Xist expression and designates the future active X. Xite, a locus associated with low-level intergenic transcripts, positively regulates Tsix expression. Thus, all known regulatory elements at the X-inactivation center make non-coding RNA. The proposed research will dissect the mechanism of action by Tsix and Xite. Specifically, the proposed research will (1) determine how Xite and Tsix inhibit the spread of Xist RNA, (2) define the molecular basis of X-inactivation imprinting and choice, and (3) test if Xite is the Xce (""""""""X-controlling element""""""""), the long-elusive modifier of XCI allele ratios which has been implicated in unfavorable skewing of XCI in female carriers of X-linked disease. As one of very few antisense loci in mammals, Tsix serves as a paradigm for antisense regulation. As one of only two known functional intergenic transcription elements in mammals, Xite will advance a limited knowledge of this emerging intergenic phenomenon. Information gained from the research program will also have significant impact on human genetics, cancer, and animal cloning, as well as on the basic biology of chromosomes, chromatin structure, and transcriptional regulation.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM058839-07
Application #
6834626
Study Section
Cell Development and Function Integrated Review Group (CDF)
Program Officer
Carter, Anthony D
Project Start
1999-01-01
Project End
2007-12-31
Budget Start
2005-01-01
Budget End
2005-12-31
Support Year
7
Fiscal Year
2005
Total Cost
$341,960
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199
Matoba, Shogo; Wang, Huihan; Jiang, Lan et al. (2018) Loss of H3K27me3 Imprinting in Somatic Cell Nuclear Transfer Embryos Disrupts Post-Implantation Development. Cell Stem Cell 23:343-354.e5
Chu, Hsueh-Ping; Cifuentes-Rojas, Catherine; Kesner, Barry et al. (2017) TERRA RNA Antagonizes ATRX and Protects Telomeres. Cell 170:86-101.e16
Chu, Hsueh-Ping; Froberg, John E; Kesner, Barry et al. (2017) PAR-TERRA directs homologous sex chromosome pairing. Nat Struct Mol Biol 24:620-631
Del Rosario, Brian C; Del Rosario, Amanda M; Anselmo, Anthony et al. (2017) Genetic Intersection of Tsix and Hedgehog Signaling during the Initiation of X-Chromosome Inactivation. Dev Cell 43:359-371.e6
Sun, Sha; Payer, Bernhard; Namekawa, Satoshi et al. (2015) Xist imprinting is promoted by the hemizygous (unpaired) state in the male germ line. Proc Natl Acad Sci U S A 112:14415-22
Kung, Johnny T; Kesner, Barry; An, Jee Young et al. (2015) Locus-specific targeting to the X chromosome revealed by the RNA interactome of CTCF. Mol Cell 57:361-75
Yang, Lin; Froberg, John E; Lee, Jeannie T (2014) Long noncoding RNAs: fresh perspectives into the RNA world. Trends Biochem Sci 39:35-43
Lee, Jeannie T; Bartolomei, Marisa S (2013) X-inactivation, imprinting, and long noncoding RNAs in health and disease. Cell 152:1308-23
Sun, Sha; Del Rosario, Brian C; Szanto, Attila et al. (2013) Jpx RNA activates Xist by evicting CTCF. Cell 153:1537-51
Payer, Bernhard; Rosenberg, Michael; Yamaji, Masashi et al. (2013) Tsix RNA and the germline factor, PRDM14, link X reactivation and stem cell reprogramming. Mol Cell 52:805-18

Showing the most recent 10 out of 48 publications